Disease Overview：Vascular dementia（VaD）
Vascular dementia (VaD) is the second most common form of dementia after Alzheimer’s disease, resulting from impaired cerebral blood flow due to cerebrovascular pathology—such as multiple infarcts, strategic single infarcts, small vessel disease, or hypoperfusion. Clinical presentation varies depending on lesion location and burden but commonly includes stepwise cognitive decline, executive dysfunction, gait disturbances, urinary incontinence, and mood lability. Diagnosis relies on neuroimaging (MRI or CT) demonstrating vascular lesions consistent with cognitive impairment, supported by neuropsychological assessment and exclusion of alternative etiologies. Unlike neurodegenerative dementias, VaD progression may stabilize or partially improve with aggressive vascular risk factor management—including hypertension, diabetes, hyperlipidemia, and atrial fibrillation control—as well as antiplatelet therapy and lifestyle interventions.
China offers distinct advantages for international patients seeking VaD evaluation and management. Leading neurology centers—particularly in Beijing, Shanghai, and Guangzhou—feature multidisciplinary stroke and cognitive disorder units staffed by specialists trained in both Western and integrative approaches. Advanced neuroimaging (3T MRI with ASL, DTI, and SWI), digital cognitive biomarkers, and AI-assisted lesion quantification support precise subtyping and longitudinal monitoring. Published outcomes from institutions like Peking Union Medical College Hospital and Huashan Hospital demonstrate improved functional independence and reduced 1-year recurrence rates through protocol-driven secondary prevention. Treatment the US, UK, or Germany—often 40–60% less for comprehensive neurovascular assessment and personalized rehabilitation planning—without compromising clinical rigor or evidence-based standards.
As a dedicated medical tourism agency, we facilitate seamless access to these resources: verifying hospital accreditation, coordinating specialist consultations, arranging interpreter-supported appointments, and providing itemized, upfront pricing with no hidden fees. Our case managers accompany patients throughout the journey—from pre-travel risk stratification to post-discharge tele-neurology follow-up—ensuring continuity of care aligned with individual prognostic and therapeutic goals.
Vascular dementia: treatment in China helps patients compare specialist hospitals, initial assessment steps and estimated costs that may vary by city, institution and clinical condition.
Medical Treatment Guide
Treatment Options & Itemized Cost Breakdown: Vascular Dementia (Neurology Department)
I. Non-Surgical / Conservative / Medication-Based Management
*Target Criteria:* Mild–moderate vascular dementia; stable cerebrovascular status; no acute stroke or uncontrolled hypertension/diabetes.
- •Standard Pharmacotherapy (3-month course)
- Aspirin 100 mg/day: $8 - Atorvastatin 20 mg/day: $26 - Antihypertensive (amlodipine 5 mg/day): $14
- •Diagnostic Workup (One-time, mandatory baseline)
- Neuropsychological battery (MoCA, ADAS-Cog, clock drawing): $68 - Blood tests: CBC, lipid panel, HbA1c, homocysteine, renal function: $47
- •Non-Pharmacologic Interventions (per 12-week program)
- Supervised physical therapy (gait/balance training): $210
II. Surgical / Procedural / Interventional Options
*Eligibility Criteria:* Documented high-grade carotid stenosis (>70%) *with* recent ipsilateral TIA/stroke *and* confirmed hemodynamic compromise on perfusion MRI/SPECT; no contraindications to surgery or antiplatelet therapy.
- •Carotid Endarterectomy (CEA)
- Procedure fee (surgeon + anesthesia + OR time): $2,850 - 3-day inpatient stay (neurology ward, monitoring): $420 - Total range: $3,300–$3,500
- •Carotid Artery Stenting (CAS)
- Procedure fee (stent + neuroprotection device + angiography): $4,100 - 2-day inpatient stay: $280 - Total range: $4,500–$4,700
III. Special / Complex Condition Management
- •Recurrent Lacunar Stroke with Progressive Dementia:
- Advanced neuroimaging (ASL-MRI + DTI tractography): $320
- •Severe Small Vessel Disease with White Matter Hyperintensities (Fazekas 3):
- Intravenous cilostazol (off-label, 3-month course): $1,080
IV. Quick Selection Guide
- •Age < 75, Budget-Constrained, Mild Dementia: Start with pharmacotherapy + cognitive rehab ($430 total first quarter) — highest cost-effectiveness ratio.
- •Age 75–85, Moderate Dementia, Carotid Stenosis >70% + Recent TIA: CEA preferred over CAS ($3,400 vs $4,600) — lower perioperative risk in elderly.
- •Age > 85, Severe Comorbidities (CHF, CKD Stage 4), No Large-Vessel Stenosis: Focus on non-pharmacologic rehab + BP/glucose optimization ($505 initial outlay) — avoids procedural risk.
- •Rapid Decline Post-Stroke, Fazekas 3, Hypertension Uncontrolled: Combine intensive BP management + cilostazol ($1,270 first quarter) — targets underlying small vessel pathology.
Pricing & Service Differences: International / VIP Dept vs. Regular Clinic
International Medical Services (IMS / VIP Departments) at Grade-3A public hospitals and private international clinics operate under self-regulated VIP fee schedules. Fees are higher than standard public clinics (which are subsidized solely for domestic citizens and do not accept overseas insurances). In exchange, international patients receive 6 exclusive medical privileges:
Recommended Hospitals
Explore selected Grade 3A public hospitals in China with rich clinical experience for this condition:
🌴 Recommended Vascular dementia Medical Vacation Packages
Curated transparent all-inclusive packages combining Vascular dementia treatment with China top medical destinations:
